Biovian bringing latest ‘gene to finished vial’ offers to BIO-Europe
Press Release | Biovian Ltd
OCTOBER 19, 2015
Turku, Finland: – Specialist biopharmaceutical CMO Biovian is sending a strong team to November’s prestige BIO-Europe biotechnology partnering conference in Munich.
The Biovian team, led by CEO Dr. Knut Ringbom will present latest developments in the Finnish-based manufacturer’s distinctive “gene to finished vial” end-to-end cGMP service.
Biovian will be an exhibitor at the event with its Booth 1 in Hall B1 of Munich’s ICM international conference center displaying key features of its cGMP services, including microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish and master cell banking.
Biovian is a regular presence at BIO-Europe events and attended the Spring conference in Paris in March.
“BIO-Europe is one of our favorite events with an audience and agenda that are ideal for our company,” said Knut Ringbom.
“This is a great place to meet many of our existing customers along with new potential partners,” said Dr. Ringbom.
“Via the online partnering system, we will be available to provide in-depth information on our biopharmaceutical manufacturing facilities and latest developments that have turned Biovian into a genuine ‘one stop shop’ CMO for cGMP biopharmaceutical manufacturing,” he added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 2,700 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labeling, packaging, storage and QP release services.
Biovian also provides development services that cover cell line, process and analysis.
About BIO-Europe 2015
The BIO-Europe® Conference is the flagship conference for EBD Group, providing life science companies with high caliber knowledge sharing and partnering opportunities.
BIO-Europe 2015 event is a three-day event opening November 2 at Munich’s ICM international conference center.
BIO-Europe has formed the launchpad for many highly successful business partnerships, drawing delegates from all parts of the biotechnology value chain to identify, engage and enter into strategic relationships.
This year´s BIO-Europe partnering event will again draw over 3,000 industry attendees from nearly 60 countries, representing more than 1,800 companies for three days of high level networking.
Partnering at BIO-Europe 2015 is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with multiple company targets.
More information at: http://www.ebdgroup.com/bioeurope/index.php
Name: Dr. Knut Ringbom, CEO, Biovian Ltd
Tel: +358 2 27488 77
Click on Biovian bringing latest ‘gene to finished vial’ offers to BIO-Europe for other information.
Click on Biovian to contact the company directly.